Through the combined efforts of agencies and organizations in the public and private sector, drugs have been made available that would not have been at hand without a specific focus on the orphan drug issue. It is anticipated that these cooperative efforts will continue beyond the first enthusiastic burst engendered by the inception of new and interesting activities.6429731PMCnul
Background More than 6,800 rare diseases and conditions have been identified in the US, which affect...
Industrial medicinal products are not always available for the treatment of some specific patients o...
While orphan drug regulations have proven to be an effective tool in stimulating the development of ...
Medical drugs of limited commercial interest (Orphan Drugs) represent a public policy dilemma. Debat...
Background The Orphan Drug Act (1983) established several incentives to encourage the development o...
Background: The Orphan Drug Act (1983) established several incentives to encourage the development o...
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of MoldovaThe aim of t...
significant changes within the pharmaceutical industry regarding resources expended to develop produ...
The development of vaccines against rare emerging infectious diseases is hampered by many disincenti...
The development of vaccines against rare emerging infectious diseases is hampered by many disincenti...
Abstract Background The Orphan Drug Act was enacted in 1983 to encourage the development of drugs fo...
Orphan drugs and diseases are a neglected academic and scientific research area. The Orphan Drug Act...
The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many co...
In the U.S., a rare disease is one that affects fewer than 200,000 patients. There are more than 7,0...
In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public in...
Background More than 6,800 rare diseases and conditions have been identified in the US, which affect...
Industrial medicinal products are not always available for the treatment of some specific patients o...
While orphan drug regulations have proven to be an effective tool in stimulating the development of ...
Medical drugs of limited commercial interest (Orphan Drugs) represent a public policy dilemma. Debat...
Background The Orphan Drug Act (1983) established several incentives to encourage the development o...
Background: The Orphan Drug Act (1983) established several incentives to encourage the development o...
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of MoldovaThe aim of t...
significant changes within the pharmaceutical industry regarding resources expended to develop produ...
The development of vaccines against rare emerging infectious diseases is hampered by many disincenti...
The development of vaccines against rare emerging infectious diseases is hampered by many disincenti...
Abstract Background The Orphan Drug Act was enacted in 1983 to encourage the development of drugs fo...
Orphan drugs and diseases are a neglected academic and scientific research area. The Orphan Drug Act...
The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many co...
In the U.S., a rare disease is one that affects fewer than 200,000 patients. There are more than 7,0...
In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public in...
Background More than 6,800 rare diseases and conditions have been identified in the US, which affect...
Industrial medicinal products are not always available for the treatment of some specific patients o...
While orphan drug regulations have proven to be an effective tool in stimulating the development of ...